Juvenile Huntington's disease masquerading as progressive myoclonus epilepsy

Thakor B, Jagtap SA, Joshi A.

Epilepsy Behav Rep. 2021 Jul 15;16:100470. doi: 10.1016/j.ebr.2021.100470. eCollection 2021.

Caveolin-1, a novel player in cognitive decline

Tang W, Li Y, Li Y, Wang Q.

Neurosci Biobehav Rev. 2021 Jul 5;129:95-106. doi: 10.1016/j.neubiorev.2021.06.044. Online ahead of print.

Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease

Benraiss A, Mariani JN, Osipovitch M, Cornwell A, Windrem MS, Villanueva CB, Chandler-Militello D, Goldman SA.

Cell Rep. 2021 Jul 6;36(1):109308. doi: 10.1016/j.celrep.2021.109308.

An unusual presentation of Huntington's disease

Schulze Westhoff M, Osmanovic A, Meissner C, Heck J, Mahmoudi N, Hendrich C, Berding G, Seifert J, Bleich S, Frieling H, Krüger T, Groh A.

Clin Case Rep. 2021 Jul 16;9(7):e04547. doi: 10.1002/ccr3.4547. eCollection 2021 Jul.

FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders

Oli V, Gupta R, Kumar P.

J Chem Neuroanat. 2021 Aug 13;116:102012. doi: 10.1016/j.jchemneu.2021.102012. Online ahead of print.

Huntingtin and Its Role in Mechanisms of RNA-Mediated Toxicity

Heinz A, Nabariya DK, Krauss S.

Toxins (Basel). 2021 Jul 14;13(7):487. doi: 10.3390/toxins13070487.

Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease

Wang Y, Guo X, Ye K, Orth M, Gu Z.

Proc Natl Acad Sci U S A. 2021 Jul 27;118(30):e2014610118. doi: 10.1073/pnas.2014610118.

Network model of pathology spread recapitulates neurodegeneration and selective vulnerability in Huntington's Disease

Raj A, Powell F.

Neuroimage. 2021 Jul 15;235:118008. doi: 10.1016/j.neuroimage.2021.118008. Epub 2021 Mar 28.

Pet Therapy as a Nonpharmacological Treatment Option for Neurological Disorders: A Review of the Literature

Boldig CM, Butala N.

Cureus. 2021 Jul 4;13(7):e16167. doi: 10.7759/cureus.16167. eCollection 2021 Jul.

Health services utilization of Chinese patients with Huntington's disease: a cross-sectional study

Ke H, Cao X, Song Y, Cao L.

BMC Health Serv Res. 2021 Aug 12;21(1):806. doi: 10.1186/s12913-021-06826-1.

Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions

Tarnacka B, Jopowicz A, Maślińska M.

Int J Mol Sci. 2021 Jul 22;22(15):7820. doi: 10.3390/ijms22157820.

Medicolegal Aspects of Huntington Disease

McDonell KE, Brown BK, Hale L, Darby RR, Stovall J, Compas BE, Claassen DO.

J Am Acad Psychiatry Law. 2021 Aug 2:JAAPL.210008-21. doi: 10.29158/JAAPL.210008-21. Online ahead of print.

Demethyleneberberine: A possible treatment for Huntington's disease

Gupta S, Khan A, Vishwas S, Gulati M, Gurjeet Singh T, Dua K, Kumar Singh S, Najda A, Sayed AA, Almeer R, Abdel-Daim MM.

Med Hypotheses. 2021 Aug;153:110639. doi: 10.1016/j.mehy.2021.110639. Epub 2021 Jun 29.

Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders

Rana T, Behl T, Sehgal A, Mehta V, Singh S, Bhatia S, Al-Harrasi A, Bungau S.

Mol Neurobiol. 2021 Jul 2. doi: 10.1007/s12035-021-02472-0. Online ahead of print.

DNM3OS regulates GAPDH expression and influences the molecular pathogenesis of Huntington's disease

Dong X, Cong S.

J Cell Mol Med. 2021 Aug 8. doi: 10.1111/jcmm.16838. Online ahead of print.